FDA Warns of DMAA Dangers and Bans Distribution

Ennis & Ennis, P.A. reports that the FDA is warning of the dangers of DMAA and is working to ensure that any dietary supplements containing the stimulant, dimethylamylamine (DMAA) will no longer be distributed or sold in the U.S. marketplace.
 
FORT LAUDERDALE, Fla. - April 16, 2013 - PRLog -- The Food and Drug Administration (FDA) is warning of the dangers of DMAA and is working to ensure that any dietary supplements containing the stimulant, dimethylamylamine (DMAA) will no longer be distributed or sold in the U.S. marketplace. DMAA is an amphetamine derivative that has been widely used in sports supplements and is most commonly found in products promoting weight loss, performance enhancement and muscle building.  It can be extremely dangerous as it can elevate blood pressure, leading to cardiovascular issues such as heart attack, shortness of breath and tightening of the chest. DMAA may be particularly dangerous when used together with caffeine.

The FDA warnings  follow over 60 reports of illness or death associated with supplements containing DMAA. The reports include heart problems and nervous systems and/or psychiatric disorders.  To remove DMAA from the market, the FDA has warned 11 companies that dietary supplements containing DMAA are illegal.  Nearly all of the companies using DMAA agreed to cease distribution of products containing DMAA. The one company who failed to comply, USPLabs, responded to the FDA’s warnings by submitting studies challenging the FDA’s findings.  However, after the FDA reviewed the studies submitted by USPLabs,  it found the information insufficient to allow the continued use of DMAA.  According to Daniel Fabricant, director of FDA’s Division of Dietary Supplement Program, the FDA is finalizing a formal response to USPLabs to reflect its findings. The USPLabs’ products are the popular Oxy Elite Pro and Jack 3D, so consumers should cease use of these products.

The FDA’s authority over dietary supplements differs from its authority over drugs and medical devices. The FDA must take significant scientific and legal steps in order to force the removal of dietary supplements that may be unsafe or illegal as dietary supplements are subject to adifferent oversight process. With dietary supplements, there is no pre-market approval, and once it hits the market, the burden is on the FDA to prove that a product is not safe.  As the FDA continues this process, consumers are urged to check labels and avoid any supplements containing DMAA. DMAA is referred to by several other names including:

1,3- DMAA
1,3- Dimethylamylamine
1,3- Dimethylpentylamine
2-Amino-4-methylhexane
2-Hexanamine
4-Methyl-2-hexanamine
4-Methyl-2-hexylamine
Dimethylamylamine
Geranamine
Methylhexanamine
Methylhexanenamine

            Consumers are urged to report any health problems associated with supplement use to the company and to the FDA and to consult their physician before using any supplements.  Ennis & Ennis, P.A. continues to offer free, nationwide, confidential consultations to anyone who used supplements containing DMAA and suffered a cardiac event or other physical injury by calling toll free 1-800-856-6405 or by going to www.ennislaw.com and completing an online case evaluation form.
End
Email:***@ennislaw.com Email Verified
Phone:800-856-6405
Tags:Dmaa, Fda, Heart Attack, Ennis
Industry:Health, Legal
Location:Fort Lauderdale - Florida - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Ennis & Ennis, P.A. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share